Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Advicenne S. A. develops therapeutics for the treatment of rare kidney diseases. Its lead product candidate is ADV7103 for the treatment of distal renal tubular acidosis in children and adults, as well as for the treatment of cystinuria, an inherited renal tubulopathy.

Similar securities

Based on sector and market capitalization

Report issue